Literature DB >> 17684156

Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor.

Jens Köditz1, Jutta Nesper, Marieke Wottawa, Daniel P Stiehl, Gieri Camenisch, Corinna Franke, Johanna Myllyharju, Roland H Wenger, Dörthe M Katschinski.   

Abstract

The activating transcription factor-4 (ATF-4) is translationally induced under anoxic conditions, mediates part of the unfolded protein response following endoplasmic reticulum (ER) stress, and is a critical regulator of cell fate. Here, we identified the zipper II domain of ATF-4 to interact with the oxygen sensor prolyl-4-hydroxylase domain 3 (PHD3). The PHD inhibitors dimethyloxalylglycine (DMOG) and hypoxia, or proteasomal inhibition, all induced ATF-4 protein levels. Hypoxic induction of ATF-4 was due to increased protein stability, but was independent of the ubiquitin ligase von Hippel-Lindau protein (pVHL). A novel oxygen-dependent degradation (ODD) domain was identified adjacent to the zipper II domain. Mutations of 5 prolyl residues within this ODD domain or siRNA-mediated down-regulation of PHD3, but not of PHD2, was sufficient to stabilize ATF-4 under normoxic conditions. These data demonstrate that PHD-dependent oxygen-sensing recruits both the hypoxia-inducible factor (HIF) and ATF-4 systems, and hence not only confers adaptive responses but also cell fate decisions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684156     DOI: 10.1182/blood-2007-06-094441

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  97 in total

1.  Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.

Authors:  Charline Ladroue; David Hoogewijs; Sophie Gad; Romain Carcenac; Federica Storti; Michel Barrois; Anne-Paule Gimenez-Roqueplo; Michel Leporrier; Nicole Casadevall; Olivier Hermine; Jean-Jacques Kiladjian; André Baruchel; Fadi Fakhoury; Brigitte Bressac-de Paillerets; Jean Feunteun; Nathalie Mazure; Jacques Pouysségur; Roland H Wenger; Stéphane Richard; Betty Gardie
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

Review 2.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

3.  Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function.

Authors:  Jaana Hyvärinen; Mataleena Parikka; Raija Sormunen; Mika Rämet; Karl Tryggvason; Kari I Kivirikko; Johanna Myllyharju; Peppi Koivunen
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

Review 4.  Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Authors:  Vaithinathan Selvaraju; Narasimham L Parinandi; Ram Sudheer Adluri; Joshua W Goldman; Naveed Hussain; Juan A Sanchez; Nilanjana Maulik
Journal:  Antioxid Redox Signal       Date:  2013-10-31       Impact factor: 8.401

Review 5.  Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis.

Authors:  Lawrence B Gardner
Journal:  Mol Cancer Res       Date:  2010-02-23       Impact factor: 5.852

6.  Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation.

Authors:  Krista Rantanen; Juha Pursiheimo; Heidi Högel; Virpi Himanen; Eric Metzen; Panu M Jaakkola
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

Review 7.  New Insights into Protein Hydroxylation and Its Important Role in Human Diseases.

Authors:  Giada Zurlo; Jianping Guo; Mamoru Takada; Wenyi Wei; Qing Zhang
Journal:  Biochim Biophys Acta       Date:  2016-09-20

Review 8.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

9.  Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.

Authors:  Jian Fu; Mark B Taubman
Journal:  J Biol Chem       Date:  2010-01-10       Impact factor: 5.157

10.  Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype.

Authors:  K Ameri; R Luong; H Zhang; A A Powell; K D Montgomery; I Espinosa; D M Bouley; A L Harris; S S Jeffrey
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.